Newsroom

Categories: Omics & Genetics, Biotechnology, Drug Discovery & Development, Pharma, Clinical Research & Trials

EpiCypher launches Fiber-seq, a breakthrough multiomic single-molecule genomics assay

September 3, 2025

Categories: Pharma, Clinical Research & Trials

Friends of Cancer Research and MMS collaborate to develop decision frameworks for interim overall survival data in oncology trials

August 20, 2025

Categories: Healthcare, Clinical Research & Trials

Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer

June 16, 2025

Categories: Bioprocessing, Clinical Research & Trials, Corporate, Finance & Investor

Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials

January 9, 2025

Categories: Healthcare, Clinical Research & Trials, Corporate, Finance & Investor

ENEA-Tech Biomedical Foundation invests €6m in BetaGlue® Therapeutics brings 2024 funding round total to €24m

December 16, 2024

Categories: Healthcare, Clinical Research & Trials

Ceryx Medical initiates first-in-human study of the Cysoni™ RSA Pacemaker

December 9, 2024

Categories: Biotechnology, Clinical Research & Trials

Duke Street Bio announces first patient dosed in Phase I trial with DSB2455, a next deneration PARP1 selective inhibitor for the treatment of solid tumours

December 3, 2024

Categories: Omics & Genetics, Clinical Research & Trials

Azenta obtains regulatory approval for clinical long-read Whole Genome Sequencing test

November 14, 2024

Categories: Computing & Technology, Clinical Research & Trials

MMS named a finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

November 8, 2024